Tag Archives: Into

Thermo Fisher shoulders into gene therapy manufacturing with $1.7B deal for Brammer

With gene therapies becoming a hot growth area, CDMOs are figuring out how to get a bigger piece of the market. Thermo Fisher Scientific decided to buy its way in, agreeing to pay $ 1.7 billion to get viral vector producer Brammer Bio. The cash deal, slated to close by the end of the second quarter, will… Read More »

The development of brain stem cells into new nerve cells and why this can lead to cancer

Ana Martin-Villalba and her research team at the German Cancer Research Center followed stem cells along the path to neurons. The scientists analyzed at every step which genes where switched on and which of them were actually turned into new proteins. They expected to find that stem cells would simply switch their stem cell genes… Read More »